Medtronic PLC (MDT)
77.39
+0.27
(+0.35%)
USD |
NYSE |
Jul 02, 16:00
77.39
0.00 (0.00%)
After-Hours: 18:37
Medtronic Research and Development Expense (Annual): 2.735B for April 30, 2024
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| April 30, 2024 | 2.735B |
| April 30, 2023 | 2.696B |
| April 30, 2022 | 2.746B |
| April 30, 2021 | 2.493B |
| April 30, 2020 | 2.331B |
| April 30, 2019 | 2.33B |
| April 30, 2018 | 2.256B |
| April 30, 2017 | 2.193B |
| April 30, 2016 | 2.224B |
| April 30, 2015 | 1.64B |
| April 30, 2014 | 1.477B |
| April 30, 2013 | 1.557B |
| April 30, 2012 | 1.49B |
| April 30, 2011 | 1.472B |
| April 30, 2010 | 1.424B |
| April 30, 2009 | 1.355B |
| Date | Value |
|---|---|
| April 30, 2008 | 1.275B |
| April 30, 2007 | 1.239B |
| April 30, 2006 | 1.113B |
| April 30, 2005 | 951.00M |
| April 30, 2004 | 851.50M |
| April 30, 2003 | 749.40M |
| April 30, 2002 | 646.30M |
| April 30, 2001 | 577.60M |
| April 30, 2000 | 488.20M |
| April 30, 1999 | 441.60M |
| April 30, 1998 | 372.20M |
| April 30, 1997 | 325.50M |
| April 30, 1996 | |
| April 30, 1995 | 191.40M |
| April 30, 1994 | 156.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
2.331B
Minimum
2020
2.746B
Maximum
2022
2.600B
Average
2.696B
Median
2023
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Abbott Laboratories | 2.741B |
| Trinity Biotech PLC | 4.379M |
| Conmed Corp | 52.60M |
| Inari Medical Inc | 87.53M |